FDA Approves Unknown Drug — APOTEX

# FDA Approves Apotex Generic Drug Application Apotex Inc. received FDA approval for an abbreviated new drug application (ANDA077982) on August 4, 2008, expanding the company's generic pharmaceutical portfolio and positioning it to capture additional market share in the competitive U.S. generics sector. The approval reinforces Apotex's capability to bring cost-effective alternative medications to patients while supporting its revenue growth in the high-volume generic drug market.